Your browser doesn't support javascript.
loading
CRISPR/Cas9 produces anti-hepatitis B virus effect in hepatoma cells and transgenic mouse.
Zhu, Wei; Xie, Kun; Xu, Yuanjian; Wang, Le; Chen, Kaiming; Zhang, Longzhen; Fang, Jianmin.
Afiliação
  • Zhu W; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. Electronic address: zhuwei8247@aliyun.com.
  • Xie K; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  • Xu Y; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  • Wang L; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  • Chen K; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  • Zhang L; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
  • Fang J; Laboratory of Molecular Medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. Electronic address: jfang@Tongji.edu.cn.
Virus Res ; 217: 125-32, 2016 06 02.
Article em En | MEDLINE | ID: mdl-27049051
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas de Bactérias / Vírus da Hepatite B / Endonucleases / Hepatite B Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Proteínas de Bactérias / Vírus da Hepatite B / Endonucleases / Hepatite B Idioma: En Ano de publicação: 2016 Tipo de documento: Article